Skip to content

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Menu

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Menu

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Menu

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Menu

Home
Research & Development
- PrimeC
- Pipeline
About
- About Neurosense
- Team
Publications & News
- Blog
- From the Media
Investors
Contact Us

Presentations

Presentations

NeuroSense Therapeutics NRSN - Corporate Presentation

Download PDF

Download PDF
(2.4 MB)

09-799-6183
info@neurosense-tx.com
One Broadway, Broadway, Cambridge, MA, USA
Ha-Menofim 11, Herzliya, Israel

Home

Investors
Contact Us

Menu

Investors
Contact Us

Research

Pipeline
PrimeC

Menu

Pipeline
PrimeC

About

About Neurosense
Our Team

Menu

About Neurosense
Our Team

Publications

Blog
From the Media

Menu

Blog
From the Media

© NeuroSense Therapeutics 2021 All Rights Reserved | Site by: Webnoise | Privacy Policy | Terms | Accessibility